| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 138.88B | 146.57B | 131.69B | 133.39B | 121.56B | 98.44B |
| Gross Profit | 38.48B | 40.81B | 34.93B | 39.29B | 38.99B | 35.23B |
| EBITDA | 8.03B | 5.78B | 5.38B | 4.60B | 7.08B | 4.47B |
| Net Income | 67.00M | 3.55B | 1.14B | 987.00M | 2.74B | 919.00M |
Balance Sheet | ||||||
| Total Assets | 102.14B | 110.79B | 105.96B | 109.89B | 108.92B | 97.80B |
| Cash, Cash Equivalents and Short-Term Investments | 28.36B | 34.30B | 35.69B | 47.08B | 48.14B | 44.67B |
| Total Debt | 1.75B | 0.00 | 258.00M | 200.00M | 206.00M | 107.00M |
| Total Liabilities | 51.35B | 57.90B | 54.85B | 53.79B | 50.08B | 37.10B |
| Stockholders Equity | 49.74B | 51.57B | 50.11B | 55.19B | 58.07B | 57.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 273.00M | -7.37B | 133.00M | 5.61B | -7.42B |
| Operating Cash Flow | 0.00 | 2.08B | -4.67B | 3.69B | 9.19B | -4.46B |
| Investing Cash Flow | 0.00 | -665.00M | 928.00M | -2.40B | -3.13B | -3.39B |
| Financing Cash Flow | 0.00 | -2.91B | -7.01B | -2.36B | -2.49B | -314.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥418.91B | 15.76 | ― | 0.33% | 3.01% | 47.38% | |
77 Outperform | ¥168.98B | 16.53 | ― | 1.17% | 48.80% | 57.67% | |
73 Outperform | ¥543.14B | 21.16 | ― | 1.12% | -7.11% | 6.18% | |
68 Neutral | ¥53.64B | 14.25 | 4.10% | 4.16% | 11.30% | 245.85% | |
68 Neutral | ¥15.13B | 11.28 | ― | 1.40% | 11.61% | -64.29% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥27.63B | 9.01 | ― | 1.11% | -2.51% | -0.60% |